Medifast's Q4 Earnings Call: Our Top 5 Analyst Questions [Yahoo! Finance]
Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
Medifast, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medifast (NYSE:MED) had its price target lowered by analysts at Stephens from $15.00 to $12.00. They now have an "equal weight" rating on the stock.
Medifast Inc (MED) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... [Yahoo! Finance]